Seeing Is Believing
Currently out of the existing stock ratings of David Bouchey, 2 are a BUY (100%).
Analyst David Bouchey, currently employed at AEGIS,
David Bouchey’s has documented 5 price targets and ratings displayed on 1 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on RMTI, Rockwell Medical at 19-Jun-2019.
Analyst best performing recommendations are on RMTI (ROCKWELL MEDICAL).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$3
$1.86 (163.16%)
$7
8 days ago
(24-Mar-2025)
0/16 (0%)
$1.74 (138.10%)
Buy
$5
$3.86 (338.60%)
$121
4 months 18 days ago
(14-Nov-2024)
0/2 (0%)
$2.51 (100.80%)
Buy
$66
$64.32 (3828.57%)
$66
5 years 1 months 6 days ago
(27-Feb-2020)
0/4 (0%)
$59.1 (206.17%)
Buy
$121
$119.32 (7102.38%)
$121
5 years 9 months 14 days ago
(19-Jun-2019)
0/3 (0%)
$70 (159.98%)
Buy
$12
$10.86 (952.63%)
$26
8 years 4 months 24 days ago
(08-Nov-2016)
4/6 (66.67%)
$-37.61 (-75.81%)
1402
What Year was the first public recommendation made by David Bouchey?